Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
News Release
WorkersCompensation.com: WC Stakeholders Look to Get Injured Workers Into Elective Procedures
During the COVID-19 pandemic, healthcare systems around the country have restricted elective surgeries, delaying care for many injured workers.
Workers' Comp
News Release
Press Release - Pam Gore Receives Beverley Boesch Legacy Award
Coventry is pleased to announce that Nurse Consultant Pamela Gore has received the
Mitchell
News Release
Mitchell Automates Delivery of OEM Repair Procedures Based on Diagnostic Scan Results
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the Property &
Workers' Comp
Blog
Introducing Networks 2.0: Part Two
Workers’ comp networks sidestep patients’ financial challengesThis is part two of a four-part blog series on Networks in workers’ comp
Mitchell
News Release
New Account Maintenance Feature Now Available in Mitchell SmartAdvisor Platform
Mitchell recently released Account Maintenance, a new feature in its
Workers' Comp
News Release